These include somatic mutations in RASA1 in lesions from patients with capillary malformation-arteriovenous malformation (CM-AVM) and TIE2 (TEK) somatic mutations in lesions from patients with venous malformations as predominant examples [141,142,143]. This evidence concerns the gene TEK and cutaneous mastocytosis.